TrianglePUBLICATIONS · 30785826
West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2019 Apr 1
- First author
- Nitz U
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Nitz U
- type
- Author
- name
- Gluz O
- type
- Author
- name
- Clemens M
- type
- Author
- name
- Malter W
- type
- Author
- name
- Reimer T
- type
- Author
- name
- Nuding B
- type
- Author
- name
- Aktas B
- type
- Author
- name
- Stefek A
- type
- Author
- name
- Pollmanns A
- type
- Author
- name
- Lorenz-Salehi F
- type
- Author
- name
- Uleer C
- type
- Author
- name
- Krabisch P
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Nitz U
- type
- Author
- name
- Gluz O
- type
- Author
- name
- Clemens M
- type
- Author
- name
- Malter W
- type
- Author
- name
- Reimer T
- type
- Author
- name
- Nuding B
- type
- Author
- name
- Aktas B
- type
- Author
- name
- Stefek A
- type
- Author
- name
- Pollmanns A
- type
- Author
- name
- Lorenz-Salehi F
- type
- Author
- name
- Uleer C
- type
- Author
- name
- Krabisch P
- type
- Author
- bibliography ids
- nci-bib-6bc475cf6ae1073a3e84ddc7
- book metadata
- content sha256
- da56a1c232f2df30eae7be824d40f113c8679ec247150b6b6acfdc6cae50a864
- document type
- citation
- dois
- 10.1200/JCO.18.00028
- electronic publication date
- display
- 2019 Feb 20
- precision
- day
- year
- 2019
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:30785826
- immutable id
- pubmed:30785826@da56a1c232f2df30eae7be824d40f113c8679ec247150b6b6acfdc6cae50a864
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 10
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 799-808
- volume
- 37
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 30785826
- provenance
- batch id
- e808962322f3afebc564
- provider
- NCBI PubMed ESummary
- record sha256
- 562aa4ae6c565cee851b3d69e33ff53b086b6c118eb3ba6f8e1accf74759b7fe
- response sha256
- 3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
- retrieved at
- 2026-09-09T23:47:41.002093+00:00
- publication date
- display
- 2019 Apr 1
- precision
- day
- year
- 2019
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer.
Preserved source evidence · Not medical advice